Cargando…
Expression of ACE2—a Key SARS-CoV-2 Entry Factor—Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis
Autores principales: | Sala, Marc A., Markov, Nikolay S., Politanska, Yuliya, Abdala-Valencia, Hiam, Misharin, Alexander V., Jain, Manu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273230/ https://www.ncbi.nlm.nih.gov/pubmed/35363994 http://dx.doi.org/10.1165/rcmb.2021-0341LE |
Ejemplares similares
-
416: Expression of SARS-CoV-2 entry genes is not greater in the nasal mucosa of CF patients
por: Sala, M., et al.
Publicado: (2021) -
Immune response to SARS-CoV-2 in the nasal mucosa in children and adults
por: Koch, Clarissa M, et al.
Publicado: (2021) -
Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2
por: Koch, Clarissa M., et al.
Publicado: (2021) -
Cilia-related gene signature in the nasal mucosa correlates with disease severity and outcomes in critical respiratory syncytial virus bronchiolitis
por: Koch, Clarissa M., et al.
Publicado: (2022) -
Lung transplantation for patients with severe COVID-19
por: Bharat, Ankit, et al.
Publicado: (2020)